FIELD: medicine.
SUBSTANCE: in order to prevent chronic toxic hepatopathy melaxen is introduced to animals in experiment one time per day in dose 10 mg/ml through probe into stomach. Simultaneously intragastric introduction of cobalt chloride solution in dose 2 mg/kg, in terms of metal, is performed daily, to create cobalt intoxication in organism.
EFFECT: method ensures efficient prevention of cobalt hepatopathy in conditions of selected modes of pathology modelling and melaxen introduction.
2 tbl, 2 dwg, 1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF MODELLING CHRONIC TOXIC HEPATOPATHY | 2010 |
|
RU2440621C1 |
METHOD FOR PREVENTION OF CHRONIC TOXIC COAGULOPATHY IN EXPERIMENTAL ANIMALS | 2018 |
|
RU2683723C1 |
METHOD FOR PREVENTION OF TOXIC ACTION OF COBALT IN EXPERIMENTAL ANIMALS SUFFERING CHRONIC POISONING | 2010 |
|
RU2431482C1 |
METHOD FOR PREVENTING CHRONIC LEAD COAGULOPATHY IN EXPERIMENTAL ANIMALS | 2019 |
|
RU2706386C1 |
METHOD FOR PREVENTION OF CHRONIC SUBLEME COAGULOPATHY IN RATS IN EXPERIMENT | 2022 |
|
RU2788609C1 |
METHOD FOR PREVENTING CHRONIC MOLYBDENUM COAGULOPATHY | 2020 |
|
RU2739690C1 |
METHOD FOR PREVENTION OF TOXIC COAGULOPATHY IN RATS | 2022 |
|
RU2794030C1 |
METHOD FOR PREVENTION OF NEPHROTOXIC EFFECT OF MOLYBDENUM | 2020 |
|
RU2786641C2 |
METHOD FOR PREVENTION OF NEPHROTOXIC ACTION OF ANTIMONY IN RATS IN EXPERIMENT | 2023 |
|
RU2815874C1 |
METHOD OF PREVENTING CHRONIC TOXIC ARTERIAL HYPERTENSION AND CARDIOPATHY IN EXPERIMENTAL ANIMALS | 2011 |
|
RU2455985C1 |
Authors
Dates
2012-11-27—Published
2010-11-29—Filed